Danaher Corporation Stock NYSE
Stocks
DHR PRB
US2358514097
Advanced Medical Equipment & Technology
| Market Cap | 141B 121B 115B 104B 195B 13,441B 196B 1,363B 524B 6,838B 528B 517B 21,609B | P/E 2026 * |
33.8x | P/E 2027 * | 27.7x |
|---|---|---|---|---|---|
| Enterprise Value | 161B 139B 132B 119B 224B 15,409B 225B 1,563B 601B 7,840B 606B 592B 24,772B | EV / Sales 2026 * |
6.12x | EV / Sales 2027 * | 5.51x |
| Free-Float |
70.45% | Yield 2026 * |
0.7% | Yield 2027 * | 0.78% |
Last Transcript : Danaher Corporation
| 1 day | -0.78% |
| Manager | Title | Age | Since |
|---|---|---|---|
Rainer Blair
CEO | Chief Executive Officer | 62 | 01/09/2020 |
Matthew Gugino
DFI | Director of Finance/CFO | - | 28/02/2026 |
Steven Dee
CTO | Chief Tech/Sci/R&D Officer | - | 25/08/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Alan Spoon
BRD | Director/Board Member | 74 | 01/07/1999 |
Steven Rales
CHM | Chairman | 74 | 01/01/1984 |
Mitchell Rales
BRD | Director/Board Member | 69 | 01/01/1984 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.78% | +1.02% | - | - | 141B | |
| +1.10% | -0.65% | +24.10% | +18.43% | 225B | |
| -0.19% | -3.62% | +2.55% | -20.00% | 141B | |
| +2.41% | +0.67% | -19.02% | +22.09% | 130B | |
| -0.28% | -10.08% | -58.81% | -21.22% | 62.29B | |
| -2.77% | -6.15% | +8.15% | +12.69% | 48.63B | |
| -0.49% | -1.97% | -20.35% | -15.53% | 49.39B | |
| +2.66% | -2.61% | +15.94% | +29.91% | 41.42B | |
| +1.67% | -0.25% | +35.01% | +55.09% | 40.12B | |
| -0.60% | -4.41% | -20.52% | +44.06% | 31.23B | |
| Average | +0.28% | -3.42% | -3.66% | +13.95% | 85.52B | |
| Weighted average by Cap. | +0.32% | -2.50% | +0.60% | +9.84% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 26.34B 22.69B 21.49B 19.47B 36.54B 2,516B 36.72B 255B 98.13B 1,280B 98.91B 96.74B 4,045B | 28.45B 24.52B 23.21B 21.04B 39.47B 2,718B 39.67B 276B 106B 1,383B 107B 105B 4,370B |
| Net income | 4.2B 3.62B 3.43B 3.11B 5.83B 402B 5.86B 40.74B 15.67B 204B 15.79B 15.44B 646B | 5.15B 4.43B 4.2B 3.81B 7.14B 492B 7.18B 49.86B 19.17B 250B 19.33B 18.9B 790B |
| Net Debt | 20.6B 17.75B 16.81B 15.23B 28.58B 1,968B 28.72B 200B 76.75B 1,001B 77.36B 75.67B 3,164B | 16.19B 13.95B 13.21B 11.97B 22.46B 1,547B 22.57B 157B 60.32B 787B 60.8B 59.47B 2,487B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
